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pISSN 2210-9099 eISSN 2233-6052- EDITORIAL -Out of Africa, Into Global Health Security AgendaFebruary 2014 witnessed the start of two remarkable
public health events on Earth: The Ebola outbreak and
the launch of Global Health Security Agenda (GHSA).
Since the first case of the Ebola outbreak in West Africa
was confirmed, the total number of suspected and
confirmed cases in the Ebola hemorrhagic fever (EHF)
outbreak has increased to 13,268, including 8168
laboratory-confirmed cases and 4960 deaths in Guinea,
Sierra Leone, Liberia, Nigeria, Mali, Senegal, Spain,
and the United States (data as of November 4, 2014) [1].
The Ebola outbreak in West Africa stresses the ne-
cessity for immediate action to establish global health
security capacity to prevent, detect, and rapidly respond
to biological threats like Ebola. The GHSA was
launched on February 13, 2014, to secure the world from
infectious disease threats and unite nations to make new,
concrete commitments, and to elevate global health se-
curity as a national leaders-level priority [2].The G7
endorsed the GHSA in June 2014, and Finland and
Indonesia hosted commitment development meetings in
May 2014 and August 2014. Ministers and senior offi-
cials from 44 countries and leading international orga-
nizations gathered in the White House, Washington DC
to make specific commitments to implement the GHSA
and to work toward a commitment to assist West Africa
with the needed global health security capacity within 3
years.
The countries developed 11 action packages to sup-
port the GHSA. The action packages are designed to
outline measurable steps required to prevent outbreaks,
detect threats in real time, and rapidly respond to in-
fectious disease threats that may occur naturally, as a
result of laboratory accidents, or as an act of bioterror-
ism. The action packages include specific targets and
indicators that can be used as a basis to measure how
national, regional, and global capacities are developed
and maintained over the long term. The United StatesThis is an Open Access article distributed under the terms of
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to achieve the objectives of the GHSA and has placed a
priority for actions on combating antibiotic-resistant
bacteria, improving biosafety and biosecurity on a
global basis, and preventing bioterrorism [3].
Ten countries have agreed to serve on the GHSA
Steering Group, which will be chaired by Finland
starting in 2015, with representation from countries
around the world, including Canada, Chile, Finland,
India, Indonesia, Italy, Kenya, the Kingdom of Saudi
Arabia, the Republic of Korea, and the United States.
The Steering Group is charged with tracking progress,
identifying challenges, and overseeing implementation
for achieving the objectives of the GHSA in support of
international standards set by the World Health Orga-
nization, the Food and Agriculture Organization of the
United Nations, and the World Organization for Animal
Health. This includes the implementation of interna-
tionally agreed standards for core capacities, such as the
World Health Organization International Health Regu-
lations, the World Organization for Animal Health
Performance of Veterinary Services Pathway, and other
global health security frameworks. To provide
accountability and drive progress toward GHSA goals,
an independent, objective, and transparent assessment
process is necessary. In this regard, independent evalu-
ation conducted over the 5-year course of the GHSA
will help to highlight gaps and needed course correc-
tions to ensure the GHSA targets are reached.
EHF is one of the aggressive infectious pathogens
that has no vaccine and prophylaxis. Preparedness
including vaccine development, rapid treatment, and
acute diagnostic methods will be helpful in decreasing
and managing the infection as is the case with many
other infectious diseases. Development of suitable vac-
cines is the best preparedness approach that can protect
from the threat of high-risk infectious diseases.
In the current issue of the Osong Public Health and
Research Perspectives, an article reports on the brief
historical background on EHF and its vaccine develop-
ment [4]. The authors mentioned that none of the vac-
cines tested have received regulatory approval so far;
however, there is still an outbreak and spreading of EHF
in Africa. The best preparedness strategy against a crisis. Published by Elsevier Korea LLC. All rights reserved.
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viruses is to stockpile vaccines after development. As a
warning of the EHF outbreak, which has lethal fatality
just after infection, immediate vaccination will be the
most effective response against an outbreak and for
controlling the spread of infection among people living
in the most susceptible regions. Thus, developing
effective vaccines is essential. Above the development
of this kind of vaccine against high-risk pathogens such
as Ebola virus, patient safety is much more important
than the efficacy to prevent potential accidents. The
authors conclude that the Ebola virus may be eradicated
using a safe and efficient vaccine similar to the case of
the smallpox virus, which was completely eliminated
using the variola vaccine developed by Edward Jenner
[4].
The authors’ conclusion is somewhat hackneyed, but
it is true that until the development of a suitable vaccine,
rapid detection, response, and control measures should
be carried out on a global basis. The GHSA could
support the countries in need until the development of
such a vaccine.
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